Vault-13

SOLENO THERAPEUTICS INC SLNO

COM NEW · Common Stock · CUSIP 834203200

1 institutional holders +0 vs Q1 2024
550,000550.0k shares reported held*
$22.4mreported value*
0 new 0 added 0 reduced 0 sold out net bought ≈ $0

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $40.80.

Trends to Q2 2024

Institutional holders

Managers reporting a position, each quarter

012Q3 22: 2Q4 22: 0Q1 23: 0Q2 23: 0Q3 23: 0Q4 23: 0Q1 24: 1Q2 24: 11Q3 22Q1 23Q3 23Q1 24Q2 24
Numbers
QuarterHolders
Q3 20222
Q4 20220
Q1 20230
Q2 20230
Q3 20230
Q4 20230
Q1 20241
Q2 20241

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
202Q4 22: 0 bought or addedQ4 22: 2 cut or sold outQ4 22Q2 24: 0 bought or addedQ2 24: 0 cut or sold outQ2 24
Numbers
QuarterBought or addedCut or sold out
Q4 202202
Q2 202400

Holders, Q2 2024

#ManagerLocationShares Value% of their portfolioChangeShares change
1 TCG Crossover Management, LLC 2.34% of their portfolio PALO ALTO, CA 550,000550.0k $22.4m $22.4m 2.34% Unchanged